Applications from the field of Pharma & Biopharma - page 1
Measurement of Elemental Impurities in Pharmaceutical Products by ICP-AES and ETAAS
Applications
| 2013 | Shimadzu
AAS, GD/MP/ICP-AES
Instrumentation
AAS, GD/MP/ICP-AES
Industries
Pharma & Biopharma
Analysis of Harmful Elements in Herbal Medicines by ICPE-9800 Series
Applications
| 2015 | Shimadzu
GD/MP/ICP-AES
Instrumentation
GD/MP/ICP-AES
Industries
Pharma & Biopharma
Analysis of Residual Catalysts in Pharmaceuticals Using ICP Atomic Emission Spectrometry
Applications
| 2010 | Shimadzu
GD/MP/ICP-AES
Instrumentation
GD/MP/ICP-AES
Industries
Pharma & Biopharma
Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030
Applications
| 2016 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma
Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030
Applications
| 2016 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma
Analysis of Herbal Medicines by ICPE-9000
Applications
| 2012 | Shimadzu
GD/MP/ICP-AES
Instrumentation
GD/MP/ICP-AES
Industries
Pharma & Biopharma
Analysis by ICP Atomic Emission Spectrometry in Accordance with the ICH Q3D Guideline for Elemental Impurities Using ICPE-9820
Applications
| 2015 | Shimadzu
GD/MP/ICP-AES
Instrumentation
GD/MP/ICP-AES
Industries
Pharma & Biopharma
Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES
Applications
| 2020 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma
Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)
Applications
| 2022 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma
Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D
Applications
| 2023 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma